Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 56,305 | 34,913 | 25,587 | 16,188 | 13,653 |
| Depreciation Amortization | 14,289 | 12,271 | 11,050 | 13,207 | 10,674 |
| Income taxes - deferred | 8,760 | 6,880 | -1,355 | 1,358 | 142 |
| Other Working Capital | -29,234 | -9,860 | -12,973 | 2,329 | 8,471 |
| Loans | -4,572 | -3,694 | -2,925 | -3,749 | -151 |
| Other Operating Activity | 14,850 | 11,856 | 12,857 | 10,563 | 2,246 |
| Operating Cash Flow | $60,398 | $52,366 | $32,241 | $39,896 | $35,035 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10,623 | -7,442 | -3,697 | -2,487 | -2,160 |
| Net Acquisitions | 44,031 | 143,631 | N/A | 1,498 | N/A |
| Purchase Of Investment | -1,552,019 | -1,251,424 | -1,022,514 | -752,485 | -29,126 |
| Sale Of Investment | 1,214,979 | 990,874 | 897,326 | 545,590 | 66,143 |
| Net Loans | -794,029 | -454,423 | -302,476 | -126,637 | -274,982 |
| Other Investing Activity | 7,169 | -6,274 | -17,960 | -21,090 | 92,057 |
| Investing Cash Flow | $-1,090,492 | $-585,058 | $-449,321 | $-355,611 | $-148,068 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 416,875 | 167,368 | 31,220 | 162,223 | -62,189 |
| Debt Issued | 1,401,062 | 635,589 | 358,975 | 198,470 | 454,184 |
| Debt Repayment | -1,150,896 | -493,526 | -117,514 | -96,068 | -414,135 |
| Common Stock Issued | 7,083 | 1,223 | 864 | 79 | 55 |
| Other Financing Activity | -36,399 | -47,103 | -4,816 | -71,749 | -6,724 |
| Financing Cash Flow | $1,057,802 | $520,308 | $429,289 | $320,774 | $78,042 |
| Beginning Cash Position | 65,479 | 77,863 | 65,654 | 60,595 | 95,586 |
| End Cash Position | 93,187 | 65,479 | 77,863 | 65,654 | 60,595 |
| Net Cash Flow | $27,708 | $-12,384 | $12,209 | $5,059 | $-34,991 |
| Free Cash Flow | |||||
| Operating Cash Flow | 60,398 | 52,366 | 32,241 | 39,896 | 35,035 |
| Capital Expenditure | -10,623 | -7,442 | -3,697 | -2,487 | -2,160 |
| Free Cash Flow | 49,775 | 44,924 | 28,544 | 37,409 | 32,875 |